Quest Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1M Buy
12,037
+894
+8% +$906K 1.29% 21
2025
Q4
$12M Sell
11,143
-3,923
-26% -$3.75M 1.29% 21
2025
Q3
$11.5M Sell
15,066
-3,187
-17% -$2.37M 1.21% 24
2025
Q2
$14.2M Buy
18,253
+1,505
+9% +$1.17M 1.56% 20
2025
Q1
$13.8M Sell
16,748
-2,169
-11% -$1.8M 1.71% 19
2024
Q4
$14.6M Buy
18,917
+2,153
+13% +$1.78M 1.7% 17
2024
Q3
$14.9M Sell
16,764
-5,355
-24% -$4.81M 1.74% 17
2024
Q2
$20M Sell
22,119
-915
-4% -$732K 2.22% 11
2024
Q1
$17.9M Sell
23,034
-4,743
-17% -$3.38M 2% 13
2023
Q4
$16.2M Buy
27,777
+17,316
+166% +$10.1M 2.03% 15
2023
Q3
$5.62M Buy
10,461
+7,255
+226% +$3.74M 0.79% 39
2023
Q2
$1.5M Buy
+3,206
New +$1.34M 0.21% 62

Other funds holding LLY

Quest Investment Management's LLY Position: Q1 2026 in Review

Quest Investment Management increased its Eli Lilly (LLY) stake by 8% in Q1 2026, buying an estimated $906K and bringing the position to 12,037 shares worth $11.1M. The position accounts for 1.29% of the portfolio, ranked #21.

Quest Investment Management first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $20M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Quest Investment Management held 12,037 shares of Eli Lilly worth $11.1M as of Q1 2026.
  • Quest Investment Management bought 894 Eli Lilly shares in Q1 2026, an estimated $906K.
  • Eli Lilly made up 1.29% of Quest Investment Management's portfolio in Q1 2026, its #21 holding.
  • Quest Investment Management first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • Quest Investment Management's Eli Lilly position peaked at $20M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Quest Investment Management's 13F filing for Q1 2026, filed 15 May 2026.